Statement of Use

BASAGLAR

Eli Lilly and Company

Trademark/Service Mark Statement of Use

PTO- 1553
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 87752275
LAW OFFICE ASSIGNED LAW OFFICE 119
EXTENSION OF USE NO
MARK SECTION
MARK FILE NAME http://uspto.report/TM/87752275/mark.png
LITERAL ELEMENT BASAGLAR
STANDARD CHARACTERS NO
USPTO-GENERATED IMAGE NO
OWNER SECTION (current)
NAME Eli Lilly and Company
MAILING ADDRESS Lilly Corporate Center
CITY Indianapolis
STATE Indiana
ZIP/POSTAL CODE 46285
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 317-651-1346
FAX 317 276 1919
EMAIL XXXX
OWNER SECTION (proposed)
NAME Eli Lilly and Company
MAILING ADDRESS Lilly Corporate Center
CITY Indianapolis
STATE Indiana
ZIP/POSTAL CODE 46285
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 317-651-1346
FAX 317 276 1919
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Bruce W. Longbottom
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@lilly.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) longbottom_bruce@lilly.com
CORRESPONDENCE INFORMATION (proposed)
NAME Bruce W. Longbottom
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@lilly.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) longbottom_bruce@lilly.com
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 044
CURRENT IDENTIFICATION Medical information services in the field of diabetes
GOODS OR SERVICES KEEP ALL LISTED
FIRST USE ANYWHERE DATE 10/31/2020
FIRST USE IN COMMERCE DATE 10/31/2020
SPECIMEN FILE NAME(S) \\TICRS\EXPORT18\IMAGEOUT 18\877\522\87752275\xml7 \ SOU0002.JPG
SPECIMEN DESCRIPTION Screenshot of webpage
WEBPAGE URL http://www.basaglar.com/what-is-basaglar/what-is-insulin
WEBPAGE DATE OF ACCESS 05/26/2021
REQUEST TO DIVIDE NO
PAYMENT SECTION
NUMBER OF CLASSES IN USE 1
SUBTOTAL AMOUNT [ALLEGATION OF USE FEE] 100
TOTAL AMOUNT 100
SIGNATURE SECTION
DECLARATION SIGNATURE /blongbottom/
SIGNATORY'S NAME Bruce W. Longbottom
SIGNATORY'S POSITION Assistant General Counsel
DATE SIGNED 05/26/2021
SIGNATORY'S PHONE NUMBER 317 651 1346
SIGNATURE METHOD Sent to third party for signature
FILING INFORMATION
SUBMIT DATE Wed May 26 16:41:24 ET 2021
TEAS STAMP USPTO/SOU-XX.XXX.XXX.XX-2
0210526164124361976-87752
275-78035347565f65c37b2e3
d63d198838878d3517d9bb451
b96989dde29e4d7141b-DA-41
223628-202105261514512784
30



PTO- 1553
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:
MARK: BASAGLAR (Stylized and/or with Design, see mark)
SERIAL NUMBER: 87752275


OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Eli Lilly and Company, having an address of
      Lilly Corporate Center
      Indianapolis, Indiana 46285
      United States
      Phone: 317-651-1346
      Fax: 317 276 1919
      Email: XXXX
Proposed: Eli Lilly and Company, having an address of
      Lilly Corporate Center
      Indianapolis, Indiana 46285
      United States
      Phone: 317-651-1346
      317 276 1919
      Email: XXXX

The owner is submitting the following allegation of use information:

For International Class 044:
Current identification: Medical information services in the field of diabetes

The mark is in use in commerce on or in connection with all of the goods/services, or to indicate membership in the collective organization listed in the application or Notice of Allowance or as subsequently modified for this specific class.

The mark was first used by the applicant, or the applicant's related company, licensee, or predecessor in interest at least as early as 10/31/2020, and first used in commerce at least as early as 10/31/2020, and is now in use in such commerce. The applicant is submitting one specimen for the class showing the mark as used in commerce on or in connection with any item in the class, consisting of a(n) Screenshot of webpage.
Specimen File1

Webpage URL: http://www.basaglar.com/what-is-basaglar/what-is-insulin
Webpage Date of Access: 05/26/2021

The applicant is not filing a Request to Divide with this Allegation of Use form. Correspondence Information (current):
      Bruce W. Longbottom
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@lilly.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): longbottom_bruce@lilly.com
Correspondence Information (proposed):
      Bruce W. Longbottom
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@lilly.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): longbottom_bruce@lilly.com

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $100 will be submitted with the form, representing payment for the allegation of use for 1 class.


Declaration


The signatory believes that the applicant is the owner of the mark sought to be registered.
For a trademark or service mark application, the mark is in use in commerce on or in connection with all the goods/services in the application or notice of allowance, or as subsequently modified.
For a collective trademark, collective service mark, collective membership mark application, the applicant is exercising legitimate control over the use of the mark in commerce by members on or in connection with all the goods/services/collective membership organization in the application or notice of allowance, or as subsequently modified.
For a certification mark application, the applicant is exercising legitimate control over the use of the mark in commerce by authorized users on or in connection with the all goods/services in the application or notice of allowance, or as subsequently modified, and the applicant is not engaged in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.
The specimen(s) shows the mark as used on or in connection with the goods/services/collective membership organization in commerce.
To the best of the signatory's knowledge and belief, no other persons, except, if applicable, authorized users, members, and/or concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.



Signature: /blongbottom/      Date Signed: 05/26/2021
Signatory's Name: Bruce W. Longbottom
Signatory's Position: Assistant General Counsel
Signatory's Phone: 317 651 1346
Signature method: Sent to third party for signature

PAYMENT: 87752275
PAYMENT DATE: 05/26/2021

Serial Number: 87752275
Internet Transmission Date: Wed May 26 16:41:24 ET 2021
TEAS Stamp: USPTO/SOU-XX.XXX.XXX.XX-2021052616412436
1976-87752275-78035347565f65c37b2e3d63d1
98838878d3517d9bb451b96989dde29e4d7141b-
DA-41223628-20210526151451278430



Statement of Use [image/jpeg]

Statement of Use [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed